Use of High-Intensity Statin Therapy Post-Acute Coronary Syndrome in the Ongoing ODYSSEY OUTCOMES Trial of Alirocumab, A Proprotein Convertase Subtilisin/Kexin type 9 Monoclonal Antibody, Versus Placebo: Interim Baseline Data

Saved in:
Bibliographic Details
Published in:Heart, lung & circulation lung & circulation, 2017, Vol.26, p.S304-S304
Main Authors: White, H., Goodman, S., Schwartz, G., Bhatt, D., Bittner, V., Diaz, R., Hanotin, C., Harrington, R., Jukema, J., Moryusef, A., Pordy, R., Roe, M., Sasiela, W., Szarek, M., Tamby, J., Zeiher, A., Steg, P.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1443-9506
1444-2892
DOI:10.1016/j.hlc.2017.06.604